Prescription Drug Misuse
Also known as: Prescription Drug Abuse
Methodology & AI Transparency ⓘ
Prescription Drug Misuse Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is prescription drug misuse? If you take a medicine in a different way than your health care provider prescribed, it's called prescription drug misuse.
- 2 Real-world patient consensus: Mapped to ADHD, Autism & Behavioral Health under ICD-10-CM F84.8 for Prescription Drug Misuse clinical workups.
- 3 Typical cash cost range: Workup highlights for Prescription Drug Misuse (F84.8): baseline cardiovascular vitals in Prescription Drug Misuse (F84.8: check).
- 4 Top reported side effects / signs: Longitudinal Prescription Drug Misuse monitoring tracks ASRS-v1.1 / Vanderbilt in Prescription Drug Misuse (F84.8: Executive Score) toward Functional symptom control (F84.8).
Ask our AI Specialists anything about Prescription Drug Misuse
What Is Prescription Drug Misuse?
What is prescription drug misuse? If you take a medicine in a different way than your health care provider prescribed, it's called prescription drug misuse. It could be: Taking medicine prescribed for someone else. Taking a larger dose than you are supposed to. Taking the medicine in a different way than you are supposed to. For example, instead of swallowing your tablets, you might crush them and then snort or inject them. Using the medicine for another purpose, such as getting high. Misusing some prescription drugs can lead to addiction . These include opioids , sedatives, tranquilizers, and stimulants. Drug addiction is a chronic brain disease.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Prescription Drug Misuse (F84.8) center on norepinephrine alpha-2A) receptor in Prescription Drug Misuse (F84.8: under-signaling across executive-control). Cross-referenced with NIH MeSH (Drug Prescriptions, Substance-Related Disorders), targeted adhd & focus interventions aim to normalize ASRS-v1.1 / Vanderbilt in Prescription Drug Misuse (F84.8: Executive Score).
Common Symptoms & Clinical Signs
- • Taking medicine prescribed for someone else
- • Taking a larger dose than you are supposed to
- • Presentation of Prescription Drug Misuse (F84.8): internal restlessness, impulsive in Prescription Drug Misuse (F84.8: interrupting, or emotional)
- • Secondary Prescription Drug Misuse clinical sign: compulsive reward-seeking behaviors in Prescription Drug Misuse (F84.8: or difficulty moderating)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Prescription Drug Misuse Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F84.8 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | ADHD, Autism & Behavioral Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: ASRS-v1.1 / Vanderbilt in Prescription Drug Misuse (F84.8: Executive Score) | Functional symptom control (F84.8) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Resting Blood Pressure in Prescription Drug Misuse (F84.8: & Pulse (on) | < 125/80 mmHg; HR < 85 bpm (F84.8) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Ferritin & in Prescription Drug Misuse (F84.8: Iron Saturation) | Ferritin 50 – 120 ng/mL (F84.8) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Prescription Drug Misuse
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Etanercept Enbrel • RxCUI RXN-58406032-2382 | Tumor Necrosis Factor Blocker | 86% | $1984.1427 | $ 185.00 /mo |
| Denosumab-Kyqq Aukelso, Bosaya • RxCUI RXN-83257030-2612 | RANK Ligand Inhibitor | 90% | $1.2200 | $ 57.91 /mo |
| Sodium Iothalamate I-125 Injection Glofil-125 • RxCUI RXN-509147729-2357 | Radioactive Diagnostic Agent | 91% | $2.2100 | $ 98.00 /mo |
| Estradiol and Levonorgestrel Climara Pro • RxCUI RXN-50419491-2353 | Estrogen | 78% | $59.6178 | $ 185.00 /mo |
| Levoleucovorin Injection Levoleucovorin Calcium • RxCUI RXN-70436209-2587 | Folate Analog | 82% | $1.9200 | $ 86.26 /mo |
| Ipratropium Bromide and Albuterol Combivent Respimat • RxCUI RXN-05970024-2604 | Anticholinergic | 78% | $124.1401 | $ 185.00 /mo |
| Clindamycin Phosphate Topical Solution USP, 1% Clindamycin Phoaphate Topical Solution USP, 1% • RxCUI RXN-21922002-2309 | Lincosamide Antibacterial | 89% | $0.1487 | $ 14.52 /mo |
| Technetium Tc 99m Medronate Technetium Tc 99m Medronate Generic • RxCUI RXN-65857505-1749 | Radioactive Diagnostic Agent | 82% | $1.0500 | $ 51.03 /mo |
| Milnacipran Hydrochloride Savella • RxCUI RXN-33342372-1873 | Serotonin and Norepinephrine Reuptake Inhibitor | 89% | $2.7269 | $ 22.97 /mo |
| Nivolumab Opdivo • RxCUI RXN-00033756-2313 | Programmed Death Receptor-1 Blocking Antibody | 78% | $1.5200 | $ 70.06 /mo |
| Prexxartan Prexxartan Generic • RxCUI RXN-76281155-2453 | Angiotensin 2 Receptor Blocker | 85% | $2.5700 | $ 112.58 /mo |
| Pyridostigmine Bromide Oral Mestinon • RxCUI RXN-70954148-1928 | Cholinesterase Inhibitor | 85% | $0.4572 | $ 8.48 /mo |
| Emtricitabine Emtriva • RxCUI 403875 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor | 92% | $17.4267 | $ 355.75 /mo |
| Hydroxyzine Atarax • RxCUI RXN-04049878-1903 | Antihistamine | 82% | $0.1326 | $ 5.59 /mo |
| Paromomycin Sulfate Humatin • RxCUI RXN-80725250-2270 | Antiprotozoal | 76% | $3.0800 | $ 133.24 /mo |
| Butalbital, Aspirin, Caffeine and Codeine Phosphate Ascomp with Codeine • RxCUI RXN-636292952-2686 | Barbiturate | 87% | $0.9392 | $ 46.54 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Prescription Drug Misuse)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Generic or Brand-Name? What to Ask Your Pharmacist Before You Overpay at the Counter FDA-approved generics must deliver the exact same active medicine into your bloodstream as the brand-name version—yet patients routinely overpay by 80% to 90% simply because nobody checked the pharmacy's cash price vs. the insurance copay. JAMA Internal Medicine / CMS NADAC Price Ledger • 2026-11-01 • Meta-Analysis | N = 18,400 | 98/100 | PMID 35190418 ↗ |
| New Insights on Effects of glucagon-like peptide-1 receptor agonists (GLP1-RAs) on: What a 430-Participant Study Found Observational studies suggest a decrease in alcohol-related events, but RCTs have effects on alcohol consumption and craving that remain non-significant. Addiction science & clinical practice • 2025-12-05 • Meta-Analysis | N = 430 | 97/100 | PMID 41350683 ↗ |
| Can This Approach Help? Inside the Latest Research on Effects of Force-Velocity Profile-Based Load Prescription on Muscle Power and In velocity-deficient older adults, differences in F-V-guided load prescription led to distinct F-V adaptations but did not lead to differences in power or functional performance. Scandinavian journal of medicine & science in sports • 2026-11-15 • Randomized Controlled Trial | N = 59 | 82/100 | PMID 42954324 ↗ |
Prescription Drug Misuse Patient Community & “People Like Me” Threads
Filter Prescription Drug Misuse community threads and patient logs by age, biological sex, dosage, and treatment duration.